Pythag Tech Raises $4.25M Seed for Cultivated Meat AI

Anne-Sophie Mertgen has worked on cultivated-meat manufacturing through 2 companies. The biomedical engineer, previously a founder of Micro Meat, is now co-founder and chief R&D officer at Pythag Tech, developing production processes that food companies can license. Her continuing assignment puts a scientific career inside a familiar industrial question: how much of the technology behind a product should a manufacturer have to invent?

New York-based Pythag announced $4.25M in Seed funding on October 22, 2026. Azolla Ventures led the round, with Endurance28 and other institutional investors participating. The capital will expand the company's biological dataset and machine-learning platform, supporting research across cell lines, growth media and bioprocessing.

Pythag's commercial proposition gives food producers access to processes developed through that research. The company generates experimental data and uses models to help determine further laboratory work, while customers would manufacture the resulting food. The financing backs that division of responsibility, with the practical value of the research ultimately tied to production conditions beyond Pythag's own experiments.

What Pythag's $4.25M Seed finances

Pythag is investing in the capacity to learn from biology. Its announcement identifies dataset and machine-learning expansion as the purpose of the Seed round, connecting the collection of physical observations with the development of models that use them. For a company selling production knowledge, those activities are part of making the eventual offering.

CEO and co-founder Sami Nabulsi described more specific spending plans in an interview with Green Queen. The company intends to acquire automation equipment, grow its laboratory and AI teams, and establish a second laboratory in Thailand alongside its Melbourne operation. These are planned uses of capital, with no opening date given for the additional lab.

That mix of spending gives the AI investment an unusually tangible shape. Equipment and researchers create observations that a model can examine; computational work helps choose which possibilities deserve an experiment. The productivity of either group depends partly on the questions the other can answer, making coordination between the bench and the model a consequential management task.

The announced $4.25M is the size of this Seed round. Pythag has not disclosed a valuation or enough prior-round information to establish lifetime funding. The useful financial conclusion is specific: Azolla and its fellow investors are financing an expansion of the research platform, including the experimental operation behind it.

How experiments become a licensable production process

Pythag concentrates on 3 connected parts of cultivated-meat production: the cells being grown, the growth media supplying their nutrients and the bioprocess used to grow them. The company describes machine learning that draws on its own biological data to identify further experiments. Their results become additional material for the next cycle of analysis.

For a producer, these choices arrive together inside a manufacturing plan. A cell line has to be considered alongside what it consumes and the environment in which it grows. Optimizing one element in isolation can leave the manufacturer with questions about the rest of the process, so Pythag's scope reaches across the relationship between all 3.

This is also where the licensing model becomes commercially interesting. A food company could use an external research capability while concentrating its own resources on manufacturing and selling food. Pythag would need to supply knowledge useful enough for that decision, including an understandable connection between experimental findings and the process being proposed.

The platform's public description leaves room for technical diligence. Pythag has not published the cost or cell-density figures needed to calculate commercial manufacturing economics, and its claim to a distinctive dataset is company positioning. Buyers can ask how a proposed process performs for their product and equipment without treating the existence of an AI model as the answer to those questions.

The founders bring different responsibilities to the same lab

Sami Nabulsi and Anne-Sophie Mertgen founded Pythag in 2023, according to the CEO's interview. Nabulsi is CEO, Mertgen leads R&D, Haytham Samad is CTO and Tiziano Barberi is chief science officer. The leadership group puts commercial direction, software, experimental research and cell biology within the same company.

Mertgen's earlier work gives that structure a longer history than the funding announcement. Y Combinator's Micro Meat profile identifies her as a founder and describes her biomedical-engineering PhD from ETH Zurich. The profile connects her move into cultivated meat with both Micro Meat and Pythag, establishing a continuing technical focus without implying that the 2 companies merged or share the same business.

Pythag's current website describes its role as enabling meat producers to add cultivated meat to their businesses. That choice gives its scientific team a customer whose existing expertise may be in food production. Translating research into something that customer can operate becomes part of the supplier relationship, alongside the research itself.

Azolla's announcement of the investment places lower production cost at the center of the investment case. The fund's co-founder and general partner Matthew Nordan frames cultivated meat's opportunity around functional equivalence and cost. His participation in the announcement supplies investor rationale, rather than evidence of a Pythag board appointment or an independently verified cost result.

Where the food manufacturer enters the research

Pythag's intended customer brings a particular food product and a set of operating requirements to the proposed license. The research platform has to make its findings useful in that setting. Commercial terms, named paying customers and quantified manufacturing outcomes remain undisclosed in the materials reviewed, leaving those discussions to develop beyond the financing announcement.

The company belongs to a wider class of AI businesses that must organize the creation of their own evidence. DevCuration's coverage of Warp Sciences' chemistry laboratories examines another relationship between physical research and model development. Pythag applies that relationship to food production, where its research output is intended to become another company's manufacturing input.

For the founders, the additional laboratory and AI capacity enlarge the range of questions they can investigate. For a prospective food-company partner, the important conversation becomes more detailed: which process fits the intended product, what further experiments are needed and how the work will carry into production. Mertgen's next research program and that manufacturer's next production decision have reasons to meet long before meat reaches a shop.